0001415889-23-015446.txt : 20231122 0001415889-23-015446.hdr.sgml : 20231122 20231122180737 ACCESSION NUMBER: 0001415889-23-015446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farnum Rhonda CENTRAL INDEX KEY: 0001898490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 231434677 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-11222023_111131.xml X0508 4 2023-11-20 0001583107 Theravance Biopharma, Inc. TBPH 0001898490 Farnum Rhonda C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, COMM & MEDICAL AFFAIRS 1 Ordinary Shares 2023-11-20 4 F 0 7982 10.37 D 332584 D Ordinary Shares 2023-11-21 4 S 0 1378 10.29 D 331206 D Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-11-22